Delta 9 Cannabis Inc Share Price Toronto S.E.
Equities
CA2477541049
Pharmaceuticals
Sales 2024 * | 75.8M 55.35M 4.42B | Sales 2025 * | 86.6M 63.24M 5.04B | Capitalization | 8.68M 6.34M 505M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.1 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.89% |
Latest transcript on Delta 9 Cannabis Inc
Managers | Title | Age | Since |
---|---|---|---|
John Arbuthnot
CEO | Chief Executive Officer | 34 | 31/12/11 |
James Lawson
DFI | Director of Finance/CFO | 73 | - |
Todd Schubert
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Hugh Aird
BRD | Director/Board Member | 70 | 06/09/18 |
Nitin Kaushal
CHM | Chairman | 58 | 30/10/17 |
John Arbuthnot
CEO | Chief Executive Officer | 34 | 31/12/11 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |